muscle loss semaglutide GLP-1 and Loss: Semaglutide, Tirzepatide & Lean Mass Semaglutide and Body Mass

Particularly noteworthy is that in patients with both type 2 diabetes and MASLD, after 24 weeks of treatment with a 10 mg dose of efinopegdutide, liver fat content reduced by 72.7%, a result that is superior to the 42.3% reduction achieved with a 1 mg dose of semaglutide, despite a similar overall weight loss being observed with the two interventions

The Bigger Picture: HSAs and Expanded Eligibility Support GLP-1 Affordability Many employees paying for GLP-1s rely on HSAs to cover these drugs tax-free to lower out-of-pocket costs

In many medically supervised weight loss programs, we consider a moderate increase in protein intake during active weight loss

Data Availability Statement No new data were created as the present was a narrative review.

Moreover, -hydroxybutyrate, an organic acid derived from -ketobutyrate (produced by AA catabolism) and associated with insulin resistance, was 30% lower in PBH at both fasting ( P = 0.03, FDR = 0.21) and 30 minutes after meals ( P = 0.03, FDR = 0.22), as compared with Asx (Supplemental Figure 7A)